Vasculitis-like syndrome associated with Borrelia lusitaniae infection

We report the isolation of Borrelia lusitaniae from a 13-year-old female child presenting with a vasculitis syndrome. The patient was treated with doxycycline, 100 mg bid for 20 days, and is in remission after a follow-up of 2 years. These results should alert clinicians to the fact that B. lusitani...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical rheumatology 2008-12, Vol.27 (12), p.1587-1591
Hauptverfasser: Lopes de Carvalho, I., Fonseca, J. E., Marques, J. G., Ullmann, A., Hojgaard, A., Zeidner, N., Núncio, M. S.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1591
container_issue 12
container_start_page 1587
container_title Clinical rheumatology
container_volume 27
creator Lopes de Carvalho, I.
Fonseca, J. E.
Marques, J. G.
Ullmann, A.
Hojgaard, A.
Zeidner, N.
Núncio, M. S.
description We report the isolation of Borrelia lusitaniae from a 13-year-old female child presenting with a vasculitis syndrome. The patient was treated with doxycycline, 100 mg bid for 20 days, and is in remission after a follow-up of 2 years. These results should alert clinicians to the fact that B. lusitaniae may be pathogenic in humans, highlighting that patients may be seronegative or present with minimal positive antibody titres and clinical signs that are not specific for Lyme borreliosis. In order to prevent the occurrence of more serious disease manifestations via timely treatment, the analysis by molecular methods may be a useful approach when antibody titres are uninformative.
doi_str_mv 10.1007/s10067-008-1012-z
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69788956</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2418583741</sourcerecordid><originalsourceid>FETCH-LOGICAL-c369t-cde245a5d5bd666b1f1c941f2560876df4be528928e1ba4250466f847261ab303</originalsourceid><addsrcrecordid>eNp1kE1LAzEQhoMotlZ_gBdZPHiLZrJJNjlqsSoUvKjXkN3Naup-1GQXaX-9KVsQBC8zh3nmneFB6BzINRCS3YRYRYYJkRgIULw9QFNgKcNKMXWIpiTLCE5ByQk6CWFFCKFSwTGagMwUTxWdosWbCcVQu94FXLtPm4RNW_qusYkJoSuc6W2ZfLv-I7nrvLe1M0k9BNeb1hmbuLayRe-69hQdVaYO9mzfZ-h1cf8yf8TL54en-e0SF6lQPS5KSxk3vOR5KYTIoYJCMagoF0RmoqxYbnn8kUoLuWGUEyZEJVlGBZg8JekMXY25a999DTb0unGhsHVtWtsNQQuVSam4iODlH3DVDb6Nv2kpIZXAY50hGKHCdyF4W-m1d43xGw1E7wzr0bCOhvXOsN7GnYt98JA3tvzd2CuNAB2BEEftu_W_l_9P_QFLlIZy</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>881381581</pqid></control><display><type>article</type><title>Vasculitis-like syndrome associated with Borrelia lusitaniae infection</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Lopes de Carvalho, I. ; Fonseca, J. E. ; Marques, J. G. ; Ullmann, A. ; Hojgaard, A. ; Zeidner, N. ; Núncio, M. S.</creator><creatorcontrib>Lopes de Carvalho, I. ; Fonseca, J. E. ; Marques, J. G. ; Ullmann, A. ; Hojgaard, A. ; Zeidner, N. ; Núncio, M. S.</creatorcontrib><description>We report the isolation of Borrelia lusitaniae from a 13-year-old female child presenting with a vasculitis syndrome. The patient was treated with doxycycline, 100 mg bid for 20 days, and is in remission after a follow-up of 2 years. These results should alert clinicians to the fact that B. lusitaniae may be pathogenic in humans, highlighting that patients may be seronegative or present with minimal positive antibody titres and clinical signs that are not specific for Lyme borreliosis. In order to prevent the occurrence of more serious disease manifestations via timely treatment, the analysis by molecular methods may be a useful approach when antibody titres are uninformative.</description><identifier>ISSN: 0770-3198</identifier><identifier>EISSN: 1434-9949</identifier><identifier>DOI: 10.1007/s10067-008-1012-z</identifier><identifier>PMID: 18795392</identifier><language>eng</language><publisher>London: Springer-Verlag</publisher><subject>Adolescent ; Animal vaccines ; Anti-Bacterial Agents - therapeutic use ; Borrelia - genetics ; Borrelia - immunology ; Borrelia - isolation &amp; purification ; Case Report ; Doxycycline - therapeutic use ; Female ; Genotype ; Humans ; Immunoglobulin G ; Immunoglobulin M ; Lyme Disease - complications ; Lyme Disease - diagnosis ; Lyme Disease - drug therapy ; Medicine ; Medicine &amp; Public Health ; Molecular Sequence Data ; Portugal ; Rheumatology ; Vasculitis - drug therapy ; Vasculitis - microbiology</subject><ispartof>Clinical rheumatology, 2008-12, Vol.27 (12), p.1587-1591</ispartof><rights>Clinical Rheumatology 2008</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c369t-cde245a5d5bd666b1f1c941f2560876df4be528928e1ba4250466f847261ab303</citedby><cites>FETCH-LOGICAL-c369t-cde245a5d5bd666b1f1c941f2560876df4be528928e1ba4250466f847261ab303</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s10067-008-1012-z$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s10067-008-1012-z$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27922,27923,41486,42555,51317</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18795392$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lopes de Carvalho, I.</creatorcontrib><creatorcontrib>Fonseca, J. E.</creatorcontrib><creatorcontrib>Marques, J. G.</creatorcontrib><creatorcontrib>Ullmann, A.</creatorcontrib><creatorcontrib>Hojgaard, A.</creatorcontrib><creatorcontrib>Zeidner, N.</creatorcontrib><creatorcontrib>Núncio, M. S.</creatorcontrib><title>Vasculitis-like syndrome associated with Borrelia lusitaniae infection</title><title>Clinical rheumatology</title><addtitle>Clin Rheumatol</addtitle><addtitle>Clin Rheumatol</addtitle><description>We report the isolation of Borrelia lusitaniae from a 13-year-old female child presenting with a vasculitis syndrome. The patient was treated with doxycycline, 100 mg bid for 20 days, and is in remission after a follow-up of 2 years. These results should alert clinicians to the fact that B. lusitaniae may be pathogenic in humans, highlighting that patients may be seronegative or present with minimal positive antibody titres and clinical signs that are not specific for Lyme borreliosis. In order to prevent the occurrence of more serious disease manifestations via timely treatment, the analysis by molecular methods may be a useful approach when antibody titres are uninformative.</description><subject>Adolescent</subject><subject>Animal vaccines</subject><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Borrelia - genetics</subject><subject>Borrelia - immunology</subject><subject>Borrelia - isolation &amp; purification</subject><subject>Case Report</subject><subject>Doxycycline - therapeutic use</subject><subject>Female</subject><subject>Genotype</subject><subject>Humans</subject><subject>Immunoglobulin G</subject><subject>Immunoglobulin M</subject><subject>Lyme Disease - complications</subject><subject>Lyme Disease - diagnosis</subject><subject>Lyme Disease - drug therapy</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Molecular Sequence Data</subject><subject>Portugal</subject><subject>Rheumatology</subject><subject>Vasculitis - drug therapy</subject><subject>Vasculitis - microbiology</subject><issn>0770-3198</issn><issn>1434-9949</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp1kE1LAzEQhoMotlZ_gBdZPHiLZrJJNjlqsSoUvKjXkN3Naup-1GQXaX-9KVsQBC8zh3nmneFB6BzINRCS3YRYRYYJkRgIULw9QFNgKcNKMXWIpiTLCE5ByQk6CWFFCKFSwTGagMwUTxWdosWbCcVQu94FXLtPm4RNW_qusYkJoSuc6W2ZfLv-I7nrvLe1M0k9BNeb1hmbuLayRe-69hQdVaYO9mzfZ-h1cf8yf8TL54en-e0SF6lQPS5KSxk3vOR5KYTIoYJCMagoF0RmoqxYbnn8kUoLuWGUEyZEJVlGBZg8JekMXY25a999DTb0unGhsHVtWtsNQQuVSam4iODlH3DVDb6Nv2kpIZXAY50hGKHCdyF4W-m1d43xGw1E7wzr0bCOhvXOsN7GnYt98JA3tvzd2CuNAB2BEEftu_W_l_9P_QFLlIZy</recordid><startdate>20081201</startdate><enddate>20081201</enddate><creator>Lopes de Carvalho, I.</creator><creator>Fonseca, J. E.</creator><creator>Marques, J. G.</creator><creator>Ullmann, A.</creator><creator>Hojgaard, A.</creator><creator>Zeidner, N.</creator><creator>Núncio, M. S.</creator><general>Springer-Verlag</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20081201</creationdate><title>Vasculitis-like syndrome associated with Borrelia lusitaniae infection</title><author>Lopes de Carvalho, I. ; Fonseca, J. E. ; Marques, J. G. ; Ullmann, A. ; Hojgaard, A. ; Zeidner, N. ; Núncio, M. S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c369t-cde245a5d5bd666b1f1c941f2560876df4be528928e1ba4250466f847261ab303</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Adolescent</topic><topic>Animal vaccines</topic><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Borrelia - genetics</topic><topic>Borrelia - immunology</topic><topic>Borrelia - isolation &amp; purification</topic><topic>Case Report</topic><topic>Doxycycline - therapeutic use</topic><topic>Female</topic><topic>Genotype</topic><topic>Humans</topic><topic>Immunoglobulin G</topic><topic>Immunoglobulin M</topic><topic>Lyme Disease - complications</topic><topic>Lyme Disease - diagnosis</topic><topic>Lyme Disease - drug therapy</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Molecular Sequence Data</topic><topic>Portugal</topic><topic>Rheumatology</topic><topic>Vasculitis - drug therapy</topic><topic>Vasculitis - microbiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lopes de Carvalho, I.</creatorcontrib><creatorcontrib>Fonseca, J. E.</creatorcontrib><creatorcontrib>Marques, J. G.</creatorcontrib><creatorcontrib>Ullmann, A.</creatorcontrib><creatorcontrib>Hojgaard, A.</creatorcontrib><creatorcontrib>Zeidner, N.</creatorcontrib><creatorcontrib>Núncio, M. S.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical rheumatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lopes de Carvalho, I.</au><au>Fonseca, J. E.</au><au>Marques, J. G.</au><au>Ullmann, A.</au><au>Hojgaard, A.</au><au>Zeidner, N.</au><au>Núncio, M. S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Vasculitis-like syndrome associated with Borrelia lusitaniae infection</atitle><jtitle>Clinical rheumatology</jtitle><stitle>Clin Rheumatol</stitle><addtitle>Clin Rheumatol</addtitle><date>2008-12-01</date><risdate>2008</risdate><volume>27</volume><issue>12</issue><spage>1587</spage><epage>1591</epage><pages>1587-1591</pages><issn>0770-3198</issn><eissn>1434-9949</eissn><abstract>We report the isolation of Borrelia lusitaniae from a 13-year-old female child presenting with a vasculitis syndrome. The patient was treated with doxycycline, 100 mg bid for 20 days, and is in remission after a follow-up of 2 years. These results should alert clinicians to the fact that B. lusitaniae may be pathogenic in humans, highlighting that patients may be seronegative or present with minimal positive antibody titres and clinical signs that are not specific for Lyme borreliosis. In order to prevent the occurrence of more serious disease manifestations via timely treatment, the analysis by molecular methods may be a useful approach when antibody titres are uninformative.</abstract><cop>London</cop><pub>Springer-Verlag</pub><pmid>18795392</pmid><doi>10.1007/s10067-008-1012-z</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0770-3198
ispartof Clinical rheumatology, 2008-12, Vol.27 (12), p.1587-1591
issn 0770-3198
1434-9949
language eng
recordid cdi_proquest_miscellaneous_69788956
source MEDLINE; SpringerLink Journals - AutoHoldings
subjects Adolescent
Animal vaccines
Anti-Bacterial Agents - therapeutic use
Borrelia - genetics
Borrelia - immunology
Borrelia - isolation & purification
Case Report
Doxycycline - therapeutic use
Female
Genotype
Humans
Immunoglobulin G
Immunoglobulin M
Lyme Disease - complications
Lyme Disease - diagnosis
Lyme Disease - drug therapy
Medicine
Medicine & Public Health
Molecular Sequence Data
Portugal
Rheumatology
Vasculitis - drug therapy
Vasculitis - microbiology
title Vasculitis-like syndrome associated with Borrelia lusitaniae infection
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T00%3A29%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Vasculitis-like%20syndrome%20associated%20with%20Borrelia%20lusitaniae%20infection&rft.jtitle=Clinical%20rheumatology&rft.au=Lopes%20de%20Carvalho,%20I.&rft.date=2008-12-01&rft.volume=27&rft.issue=12&rft.spage=1587&rft.epage=1591&rft.pages=1587-1591&rft.issn=0770-3198&rft.eissn=1434-9949&rft_id=info:doi/10.1007/s10067-008-1012-z&rft_dat=%3Cproquest_cross%3E2418583741%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=881381581&rft_id=info:pmid/18795392&rfr_iscdi=true